Preliminary Final Report
Filed with ASX · · 1 page · English
Summary by 6ix AI
The report indicates a substantial decline in revenues from ordinary activities compared to the previous year, alongside a notable loss after tax. No dividends were declared or proposed during this period, reflecting the company's financial challenges. The report also highlights a shift from positive net equity to a deficit by the end of the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Agreement with C14 Consulting Group
- Passing of Vectus CEO
- Quarterly Activities/Appendix 4C Cash Flow Report
- Preliminary Final Report - Appendix 4E
- Half Yearly Report & Appendix 4D
Later from Vectus Biosystems
- Pause in Trading
- Trading Halt
- Suspension from Quotation
- VB4-P5 Renal Compound Transaction
- Reinstatement to Quotation
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems